{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:26:41Z","timestamp":1778826401286,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jmirs.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Imaging and Radiation Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jmir.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T20:08:55Z","timestamp":1560629335000},"page":"454-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diffuse Primary Cutaneous Anaplastic Large Cell Lymphoma Treated by Rotational Total Skin Electron Beam Radiotherapy with Custom Shielding: Case Report"],"prefix":"10.1016","volume":"50","author":[{"given":"Alexander D.","family":"Sherry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George X.","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin N.","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jmir.2019.05.002_bib1","first-page":"1735","article-title":"Primary cutaneous anaplastic large cell lymphoma occurring in an atopic dermatitis patient: a case report with review of the literature with emphasis on their association","volume":"7","author":"Ishida","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"10.1016\/j.jmir.2019.05.002_bib2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jmir.2019.05.002_bib3","series-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","first-page":"300","article-title":"Primary cutaneous CD30-positive T-cell lymphoproliferative disorders","author":"Ralfaiaer","year":"2008"},{"issue":"20","key":"10.1016\/j.jmir.2019.05.002_bib4","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision to the World Health Organization (WHO) classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jmir.2019.05.002_bib5","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jmir.2019.05.002_bib6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/bjd.16501","article-title":"Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group","volume":"179","author":"Melchers","year":"2018","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jmir.2019.05.002_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/COC.0b013e3182185aa2","article-title":"Primary cutaneous anaplastic large-cell lymphoma","volume":"36","author":"Perry","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jmir.2019.05.002_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11307-007-0127-y","article-title":"FDG-PET\/CT in the evaluation of cutaneous T-cell lymphoma","volume":"10","author":"Kuo","year":"2008","journal-title":"Mol Imaging Biol"},{"issue":"6","key":"10.1016\/j.jmir.2019.05.002_bib9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archdermatol.2009.74","article-title":"Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome","volume":"145","author":"Woo","year":"2009","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jmir.2019.05.002_bib10","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1200\/JCO.2007.14.1374","article-title":"Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the surveillance, epidemiology, and end results database","volume":"26","author":"Yu","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jmir.2019.05.002_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/bjh.14404","article-title":"Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience","volume":"176","author":"Hapgood","year":"2017","journal-title":"Br J Haematol"},{"issue":"15","key":"10.1016\/j.jmir.2019.05.002_bib12","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jmir.2019.05.002_bib13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"CD30+cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma","volume":"49","author":"Liu","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jmir.2019.05.002_bib14","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ijrobp.2016.03.023","article-title":"Radiation therapy for primary cutaneous anaplastic large cell lymphoma: an international lymphoma radiation oncology group multi-institutional experience","volume":"95","author":"Million","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"10.1016\/j.jmir.2019.05.002_bib15","first-page":"1158","article-title":"Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders","volume":"23","author":"Kadin","year":"2009","journal-title":"Oncol Willist Park NY"},{"issue":"4","key":"10.1016\/j.jmir.2019.05.002_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00000421-198708000-00018","article-title":"Dual-field rotational (DFR) technique for total-skin electron-beam therapy (TSEBT)","volume":"10","author":"Kumar","year":"1987","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jmir.2019.05.002_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1740-8261.2011.01866.x","article-title":"The electron beam attenuating properties of SuperFlab, Play-Doh, and wet gauze, compared to plastic water","volume":"53","author":"Nagata","year":"2012","journal-title":"Vet Radiol Ultrasound"},{"key":"10.1016\/j.jmir.2019.05.002_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000475634","article-title":"Total skin electron beam therapy as part of multimodal treatment strategies for primary cutaneous T-cell lymphoma","volume":"40","author":"Elsayad","year":"2017","journal-title":"Oncol Res Treat"},{"issue":"2","key":"10.1016\/j.jmir.2019.05.002_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaad.2014.10.014","article-title":"Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials","volume":"72","author":"Hoppe","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jmir.2019.05.002_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.adro.2017.06.004","article-title":"Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma","volume":"2","author":"Smith","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"6","key":"10.1016\/j.jmir.2019.05.002_bib21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.prro.2017.03.009","article-title":"Scalp-sparing total skin electron therapy in mycosis fungoides: Case report featuring a technique without lead","volume":"7","author":"Patel","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10.1016\/j.jmir.2019.05.002_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5114\/pdia.2013.33379","article-title":"Total skin electron irradiation techniques: a review","volume":"30","author":"Piotrowski","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jmir.2019.05.002_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijrobp.2014.11.033","article-title":"Total skin electron therapy for cutaneous T-Cell lymphoma using a modern dual-field rotational technique","volume":"92","author":"Heumann","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.jmir.2019.05.002_bib24","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK - anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1016\/j.jmir.2020.11.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"container-title":["Journal of Medical Imaging and Radiation Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939865419300244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939865419300244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T22:43:11Z","timestamp":1744497791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939865419300244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1939865419300244"],"URL":"https:\/\/doi.org\/10.1016\/j.jmir.2019.05.002","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jmir.2020.11.002","asserted-by":"object"}]},"ISSN":["1939-8654"],"issn-type":[{"value":"1939-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diffuse Primary Cutaneous Anaplastic Large Cell Lymphoma Treated by Rotational Total Skin Electron Beam Radiotherapy with Custom Shielding: Case Report","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Imaging and Radiation Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmir.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of Canadian Association of Medical Radiation Technologists.","name":"copyright","label":"Copyright"}]}}